Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SEMAFORCRANIO : Multicenter, Double-blind, Parallel, Randomized Controlled Trial of the Efficacy of Semaglutide in Hypothalamic Obesity Secondary to Craniopharyngioma in Children Aged 12 to 17 Years

NCT07845994 is registered in ClinicalTrials.gov with University Hospital, Angers as lead sponsor.

NCT NCT07845994
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07845994 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SEMAFORCRANIO : Multicenter, Double-blind, Parallel, Randomized Controlled Trial of the Efficacy of Semaglutide in Hypothalamic Obesity Secondary to Craniopharyngioma in Children Aged 12 to 17 Years
Lead sponsor
University Hospital, Angers
Phase
Phase 3
Overall status
Not yet recruiting
Start date
November 30, 2026
Completion date
February 28, 2031
Enrollment
50 (estimated)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

craniopharyngioma, child